Cargando…
Access to Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma
INTRODUCTION: Geographic access to novel oncology therapies, and the extent to which it may vary by potential sites of care, regions, and population characteristics, is poorly understood. We examined how expanding access to chimeric antigen receptor (CAR) T cell therapy administration sites impacts...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408091/ https://www.ncbi.nlm.nih.gov/pubmed/34302277 http://dx.doi.org/10.1007/s12325-021-01838-z |